Silverleafe Capital Partners, LLC Pfizer Inc Transaction History

Silverleafe Capital Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 04, 2023	BUY	$41.75 - $54.5 $174,264 - $227,483	4,174 New	4,174 $0
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $182,654 - $222,975	-4,174 Closed	0 $0
Q2 2022 Jul 01, 2022	SELL	$46.53 - $55.17 $24,753 - $29,350	-532 Reduced 11.3%	4,174 $219,000
Q1 2022 Apr 05, 2022	BUY	$45.75 - $56.69 $48,769 - $60,431	1,066 Added 29.29%	4,706 $244,000
Q4 2021 Jan 04, 2022	BUY	$41.32 - $61.25 $150,404 - $222,950	3,640 New	3,640 $215,000
Q3 2019 Oct 04, 2019	SELL	$32.49 - $42.13 $1.72 Million - $2.23 Million	-52,931 Closed	0 $0
Q2 2019 Jul 03, 2019	SELL	$36.98 - $41.52 $212,080 - $238,117	-5,735 Reduced 9.78%	52,931 $2.29 Million
Q1 2019 Apr 10, 2019	BUY	$37.5 - $41.2 $150,525 - $165,376	4,014 Added 7.34%	58,666 $2.49 Million
Q4 2018 Jan 04, 2019	BUY	$38.47 - $43.86 $313,068 - $356,932	8,138 Added 17.5%	54,652 $2.39 Million
Q3 2018 Oct 05, 2018	SELL	$34.47 - $41.81 $50,119 - $60,791	-1,454 Reduced 3.03%	46,514 $2.05 Million
Q2 2018 Jul 09, 2018	SELL	$32.98 - $35.16 $189,470 - $201,994	-5,745 Reduced 10.7%	47,968 $1.74 Million
Q1 2018 Apr 20, 2018	SELL	$31.91 - $37.02 $38,483 - $44,646	-1,206 Reduced 2.2%	53,713 $1.91 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $1.83 Million - $1.94 Million	54,919	54,919 $1.99 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Silverleafe Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverleafe Capital Partners, LLC with notifications on news.